Monitoring and early warning for COPD patients on home ventilation
Part of Lungs & breathing clinical trials.
This trial tests whether real-time monitoring with wearable devices can provide early warnings for COPD patients using home non-invasive ventilation. It aims to help manage the condition and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with COPD with severe lung function (FEV1 less than 50% of predicted).
- You have chronic high carbon dioxide levels in your blood (PaCO2 at least 53 mm Hg) when stable and not having a flare-up.
- You have not had a COPD exacerbation in the last 4 weeks.
- You do not have other major lung or heart conditions that would interfere.
- You can use a ventilator mask at home and wear a monitoring device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether home telemonitoring combined with a breathing machine (non-invasive ventilation) can help people with advanced COPD and persistently high carbon dioxide levels. It aims to improve care and reduce hospital visits.
This study looks at signals from non-invasive home ventilators to better track COPD. It may help understand how to manage the condition using data from your device.
This trial tests whether using a non-invasive ventilator (a breathing machine with a mask) at home can help people with severe COPD who have high carbon dioxide levels in their blood. It aims to improve breathing and reduce the need for hospital visits.
This study tests how well a specific breathing mask setup works in people who need noninvasive ventilation (breathing support without a breathing tube), especially during COPD flare-ups or certain kinds of breathing failure. It may help reduce complications related to the mask while supporting breathing for at least a day.
This trial studies how different breathing support strategies affect people with COPD who have high carbon dioxide (CO2) in their blood. It may help care teams choose safer respiratory support after a breathing machine is stopped.
This trial compares two types of noninvasive breathing support (high-intensity vs. low-intensity) to see which is more comfortable for people with a sudden worsening of COPD. If your carbon dioxide level remains high despite initial treatment, you may be eligible.
Hear when a new Pulmonary Disease, Chronic Obstructive (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.